A Comprehensive Test System to Identify Suitable Antibodies Against p53 for Immunohistochemical Analysis of Canine Tissues

Journal of Comparative Pathology

Volumn 137, Issue 1, 2007, Pages 59-70

  Keller, S M ^a   Schade, B ^a   Rickenbacher, A B ^a   Brugnera, E ^a   Wergin, M C ^b   Muller E J ^b   Suter, M M ^b   Guscetti, F ^a  

^a Institute of Veterinary Pathology   (Switzerland)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

canine p53; dog; p53 immunolabelling; tumour

Indexed keywords

DNA; POLYCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CROSS REACTION; DNA EXTRACTION; DOG; EXON; FLUORESCENCE ACTIVATED CELL SORTING; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE MICROARRAY; ULTRAVIOLET B RADIATION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIBODIES; APOPTOSIS; CELLS, CULTURED; CROSS REACTIONS; DOGS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; RECOMBINANT PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; CANIS FAMILIARIS;

EID: 34447127686     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.04.021     Document Type: Article

References (49)

1. Albaric O., Bret L., Amardeihl M., and Delverdier M. Immunohistochemical expression of p53 in animal tumors: a methodological study using four anti-human p53 antibodies. Histology and Histopathology 16 (2001) 113-121
2. Baas I.O., Mulder J.W., Offerhaus G.J., Vogelstein B., and Hamilton S.R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. Journal of Pathology 172 (1994) 5-12
3. Bourdon J.C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D.P., Saville M.K., and Lane D.P. p53 isoforms can regulate p53 transcriptional activity. Genes & Development 19 (2005) 2122-2137
4. Chipuk J.E., and Green D.R. Dissecting p53-dependent apoptosis. Cell Death and Differentiation 13 (2006) 994-1002
5. Cruz I., Snijders P.J., Van Houten V., Vosjan M., Van der Waal I., and Meijer C.J. Specific p53 immunostaining patterns are associated with smoking habits in patients with oral squamous cell carcinomas. Journal of Clinical Pathology 55 (2002) 834-840
6. Gamblin R.M., Sagartz J.E., and Couto C.G. Overexpression of p53 tumor suppressor protein in spontaneously arising neoplasms of dogs. American Journal of Veterinary Research 58 (1997) 857-863
7. Gannon J.V., Greaves R., Iggo R., and Lane D.P. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. Embo Journal 9 (1990) 1595-1602
8. Gao J.P., Uchida T., Wang C., Jiang S.X., Matsumoto K., Satoh T., Minei S., Soh S., Kameya T., and Baba S. Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder. International Journal of Oncology 16 (2000) 469-475
9. Ginn P.E., Fox L.E., Brower J.C., Gaskin A., Kurzman I.D., and Kubilis P.S. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Veterinary Pathology 37 (2000) 33-39
10. Haga S., Nakayama M., Tatsumi K., Maeda M., Imai S., Umesako S., Yamamoto H., Hilgers J., and Sarkar N.H. Overexpression of the p53 gene product in canine mammary tumors. Oncology Reports 8 (2001) 1215-1219
11. Houldsworth J., Xiao H., Murty V.V., Chen W., Ray B., Reuter V.E., Bosl G.J., and Chaganti R.S. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 16 (1998) 2345-2349
12. Inoue M., and Shiramizu K. Immunohistochemical detection of p53 and c-myc proteins in canine mammary tumours. Journal of Comparative Pathology 120 (1999) 169-175
13. Inoue M., and Wada N. Immunohistochemical detection of p53 and p21 proteins in canine testicular tumours. Veterinary Record 146 (2000) 370-372
14. Ishida H., Irie K., Itoh T., Furukawa T., and Tokunaga O. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer 80 (1997) 1034-1045
15. Jaffe M.H., Hosgood G., Taylor H.W., Kerwin S.C., Hedlund C.S., Lopez M.K., Davidson J.R., Miller D.M., and Paranjpe M. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Veterinary Pathology 37 (2000) 40-46
16. Johnson A.S., Couto C.G., and Weghorst C.M. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis 19 (1998) 213-217
17. Johnston H.M., Thompson H., and Pirie H.M. p53 immunohistochemistry in domestic animal tumours. European Journal of Veterinary Pathology 2 (1996) 135-140
18. Kawaura Y., Tatsuzawa Y., Wakabayashi T., Ikeda N., Matsuda M., and Nishihara S. Immunohistochemical study of p53, c-erbB-2, and PCNA in barrett's esophagus with dysplasia and adenocarcinoma arising from experimental acid or alkaline reflux model. Journal of Gastroenterology 36 (2001) 595-600
19. Kirsch D.G., and Kastan M.B. Tumor-suppressor p53: implications for tumor development and prognosis. Journal of Clinical Oncology 16 (1998) 3158-3168
20. Kolly C., Suter M.M., and Muller E.J. Proliferation, cell cycle exit, and onset of terminal differentiation in cultured keratinocytes: pre-programmed pathways in control of C-Myc and Notch 1 prevail over extracellular calcium signals. Journal of Investigative Dermatology 124 (2005) 1014-1025
21. Lee C.H., Kim W.H., Lim J.H., Kang M.S., Kim D.Y., and Kweon O.K. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Journal of Veterinary Science 5 (2004) 63-69
22. Loukopoulos P., Thornton J.R., and Robinson W.F. Clinical and pathologic relevance of p53 index in canine osseous tumors. Veterinary Pathology 40 (2003) 237-248
23. McEntee M.F., and Brenneman K.A. Dysregulation of beta-catenin is common in canine sporadic colorectal tumors. Veterinary Pathology 36 (1999) 228-236
24. Munro A.J., Lain S., and Lane D.P. P53 abnormalities and outcomes in colorectal cancer: a systematic review. British Journal of Cancer 92 (2005) 434-444
25. Murakami Y., Tateyama S., Rungsipipat A., Uchida K., and Yamaguchi R. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats. Journal of Veterinary Medical Science 62 (2000) 743-750
26. Nieto A., Perez-Alenza M.D., Del Castillo N., Tabanera E., Castano M., and Pena L. BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. Journal of Comparative Pathology 128 (2003) 260-268
27. Ozaki K., Yamagami T., Nomura K., and Narama I. Mast cell tumors of the gastrointestinal tract in 39 dogs. Veterinary Pathology 39 (2002) 557-564
28. Pardo F.S., Hsu D.W., Zeheb R., Efird J.T., Okunieff P.G., and Malkin D.M. Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. British Journal of Cancer 91 (2004) 1678-1686
29. Peller S. Clinical implications of p53: effect on prognosis, tumor progression and chemotherapy response. Seminars in Cancer Biology 8 (1998) 379-387
30. Pena L., Perez-Alenza M.D., Rodriguez-Bertos A., and Nieto A. Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases. Breast Cancer Research and Treatment 78 (2003) 141-148
31. Roels S., Tilmant K., and Ducatelle R. p53 expression and apoptosis in melanomas of dogs and cats. Research in Veterinary Science 70 (2001) 19-25
32. Rungsipipat A., Tateyama S., Yamaguchi R., Uchida K., Miyoshi N., and Hayashi T. Immunohistochemical analysis of c-yes and c-erbB-2 oncogene products and p53 tumor suppressor protein in canine mammary tumors. Journal of Veterinary Medical Science 61 (1999) 27-32
33. Sagartz J.E., Bodley W.L., Gamblin R.M., Couto C.G., Tierney L.A., and Capen C.C. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs. Veterinary Pathology 33 (1996) 213-221
34. Schafer K.A., Kelly G., Schrader R., Griffith W.C., Muggenburg B.A., Tierney L.A., Lechner J.F., Janovitz E.B., and Hahn F.F. A canine model of familial mammary gland neoplasia. Veterinary Pathology 35 (1998) 168-177
35. Schlichtholz B., Tredaniel J., Lubin R., Zalcman G., Hirsch A., and Soussi T. Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein. British Journal of Cancer 69 (1994) 809-816
36. Smith, M. L., and Fornace, A. J., Jr (1997). p53-mediated protective responses to UV irradiation. Proceedings of the National Academy of Sciences of the USA, 94, 12255-12257.
37. Sokolowska J., Cywinska A., and Malicka E. p53 expression in canine lymphoma. Journal of Veterinary Medicine Series A 52 (2005) 172-175
38. Soussi T., and Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nature Reviews Cancer 1 (2001) 233-240
39. Stoica G., Kim H.T., Hall D.G., and Coates J.R. Morphology, immunohistochemistry, and genetic alterations in dog astrocytomas. Veterinary Pathology 41 (2004) 10-19
40. Sueiro F.A., Alessi A.C., and Vassallo J. Canine lymphomas: a morphological and immunohistochemical study of 55 cases, with observations on p53 immunoexpression. Journal of Comparative Pathology 131 (2004) 207-213
41. Teifke J.P., and Lohr C.V. Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs. Journal of Comparative Pathology 114 (1996) 205-210
42. Teifke J.P., Lohr C.V., and Shirasawa H. Detection of canine oral papillomavirus-DNA in canine oral squamous cell carcinomas and p53 overexpressing skin papillomas of the dog using the polymerase chain reaction and non-radioactive in situ hybridization. Veterinary Microbiology 60 (1998) 119-130
43. Van Cruchten S., Van den Broeck W., Duchateau L., and Simoens P. Apoptosis in the canine endometrium during the estrous cycle. Theriogenology 60 (2003) 1595-1608
44. Vitellozzi G., Mariotti F., and Ricci G. Immunohistochemical expression of the p53 protein in testicular tumours in the dog. European Journal of Veterinary Pathology 4 (1998) 61-65
45. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
46. Wakui S., Muto T., Yokoo K., Yokoo R., Takahashi H., Masaoka T., Hano H., and Furusato M. Prognostic status of p53 gene mutation in canine mammary carcinoma. Anticancer Research 21 (2001) 611-616
47. Wolf J.C., Ginn P.E., Homer B., Fox L.E., and Kurzman I.D. Immunohistochemical detection of p53 tumor suppressor gene protein in canine epithelial colorectal tumors. Veterinary Pathology 34 (1997) 394-404
48. Xu L., Chen Y.T., Huvos A.G., Zlotolow I.M., Rettig W.J., Old L.J., and Garin-Chesa P. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations. Diagnostic Molecular Pathology 3 (1994) 83-92
49. Zettl A., Meister M.M., Muller-Hermelink H.K., and Ott G. Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas. Histopathology 43 (2003) 209-219